Infinity Pharma's cancer drug fails mid-stage trial goals

[riky]

Infinity Pharma's cancer drug fails mid-stage trial goals

(Reuters) - Infinity Pharmaceuticals Inc said its cancer drug failed to improve overall survival in a mid-stage study on patients with non-small cell lung cancer who had a history of smoking. The drug, retaspimycin HCl, also failed to improve overall survival in patients with squamous cell carcinoma, a type of non-small cell lung cancer that is closely linked to smoking. The company said it will not start any new trials with the drug, but would complete enrollment in a separate study by the end of the year. ...

Source: You are not allowed to view links. Register or Login